In early March, Congress adopted legislation that updated the Medicare Physician Fee Schedule (MPFS) conversion factor for claims processed from March 9 to December 31, 2024. The revised conversion factor has been updated to $33.2875 reflecting a 1.68% update from the previous…
United Healthcare Home Immunotherapy Policy Change
United Healthcare has recently announced a policy change. Effective January 1, 2023, UHC will no longer cover home- and self-administered subcutaneous allergen immunotherapy. The AAOA, in conjunction with AAOHNS, is working to try to reverse this policy change.
In the meantime, we have developed a template letter you can share with your patients explaining the change and the impact on their immunotherapy, and encouraging them to bring the issue to the HR Director to apply pressure from the buyer’s side.
For those of you who participate with UHC, we recommend you consider a signed consent for the potential out-of-pocket cost to the patient for uncovered services. Additionally, if you receive any updates to this new policy, please share them with us at advocacy@aaoallergy.org.
Here you can find is a sample of the letter issued by UHC, followed by the patient letter template.